March 18th 2025
Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
CMS Releases Guidance on the Math Behind Part B, Part D Drug Rebates